Acetanilide

Acetanilide

SCHEMBL1085256

CC(=O)Nc1ccccc1.O=S(=O)(O)[AlH2]

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 1/20 0.76
HSD17B10 Q99714 1/20 0.76
KMT2A Q03164 3/20 0.66
MAPT P10636 3/20 0.66
NPC1 O15118 2/20 0.66
RAB9A P51151 2/20 0.66
TAAR1 Q96RJ0 1/20 0.66
POLB P06746 1/20 0.66
GAA P10253 2/20 0.61
IDO1 P14902 1/20 0.58
MEN1 O00255 2/20 0.57
GFER P55789 1/20 0.57
L3MBTL1 Q9Y468 2/20 0.56
ALDH1A1 P00352 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.55
CACNA1B Q00975 1/20 0.55
APBA1 Q02410 1/20 0.55
ACP1 P24666 2/20 0.53
TSHR P16473 1/20 0.53
HTT P42858 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetanilide SCHEMBL7074699 0.88 NAPRT (0.76) NAPRTHSD17B10KMT2AMAPTNPC1
Acetanilide SCHEMBL3359084 0.87 NAPRT (1.00) NAPRTHSD17B10KMT2AMAPTNPC1
Acetanilide SCHEMBL24681 0.87 NAPRT (1.00) NAPRTHSD17B10KMT2AMAPTNPC1
Acetanilide SCHEMBL1332076 0.87 NAPRT (1.00) NAPRTHSD17B10KMT2AMAPTNPC1
Acetanilide SCHEMBL16922180 0.87 NAPRT (1.00) NAPRTHSD17B10KMT2AMAPTNPC1
SCHEMBL19669626 0.87 NAPRT (1.00) NAPRTHSD17B10KMT2AMAPTNPC1
Acetanilide SCHEMBL27770798 0.86 NAPRT (0.73) NAPRTHSD17B10KMT2AMAPTNPC1
Acetanilide SCHEMBL397904 0.86 NAPRT (0.79) NAPRTHSD17B10KMT2AMAPTNPC1
Acetanilide SCHEMBL27934576 0.86 NAPRT (0.79) NAPRTHSD17B10KMT2AMAPTNPC1
Acetanilide SCHEMBL11593410 0.86 NAPRT (0.79) NAPRTHSD17B10KMT2AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1892240-B1 Benzoisoindole derivative, pigment composition comprising the same and colored composition TOYO INK MFG CO (JP) 2012-04-18 EP disclosed
US-8152863-B2 Pigment dispersion composition, red colored composition, colored curable composition, color filter for a solid state imaging device and method for producing the same, and solid state imaging device FUJIFILM CORPORATION (JP) 2012-04-10 US disclosed
EP-2392621-A2 Pigment dispersion composition, red colored composition, colored curable composition, color filter for a solid state imaging device and method for producing the same, and solid state imaging device FUJIFILM Corporation (JP) 2011-12-07 EP disclosed
US-20110294050-A1 PIGMENT DISPERSION COMPOSITION, RED COLORED COMPOSITION, COLORED CURABLE COMPOSITION, COLOR FILTER FOR A SOLID STATE IMAGING DEVICE AND METHOD FOR PRODUCING THE SAME, AND SOLID STATE IMAGING DEVICE FUJIFILM CORPORATION (JP) 2011-12-01 US disclosed
US-20080289541-A1 Benzoisoindole derivative, pigment composition comprising the same and colored composition TOYO INK MFG. CO., LTD. (JP) 2008-11-27 US disclosed
EP-1892240-A1 Benzoisoindole derivative, pigment composition comprising the same and colored composition TOYO INK MFG. CO., LTD. (JP) 2008-02-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080289541-A1 Benzoisoindole derivative, pigment composition comprising the same and colored composition TYR, BRI3BP, MITF NAPRT 769/4885HSD17B10 623/4885KMT2A 1914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.